Press release
Chronic Disease Management Market Trends That Will Shape the Next Decade: Insights from AI-Powered Solutions Transforming Chronic Disease Management
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.How Large Will the Chronic Disease Management Market Size By 2025?
The market size for chronic disease management has experienced swift expansion in the past few years. The market is projected to increase from a size of $9.55 billion in 2024 to $11.3 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 18.3%. The remarkable grow observed in the historical period can be credited to numerous factors including data analytics usage in population health management, patient empowerment through education, value-based healthcare models, personalized treatment approaches, and a prioritized focus on preventative healthcare.
How Big Is the Chronic Disease Management Market Size Expected to Grow by 2029?
The market size for managing chronic diseases is predicted to undergo a significant increase in the coming years, swelling to a value of $24.49 billion by 2029 with an annual compound growth rate of 21.3%. This projected growth during the forecast period is understood to be a result of various factors like the adoption of patient-focused care models, the aging global population, emphasis on remote patient monitoring (rpm), and the rising incidences of chronic illnesses, along with overall global health trends. The forecast period is also expected to be influenced by predominant trends such as responses to global health crises and pandemics, support through government initiatives and policies, the rise of user-friendly health apps and platforms, the exchange and interoperability of health information, a greater focus on behavioral health, and the expansion of telehealth.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report
Which Key Market Drivers Powering Chronic Disease Management Market Expansion and Growth?
The escalating numbers of older individuals, often defined as those over 65, is a major factor contributing to the expansion of the chronic disease management market. With age, there is an increased likelihood of developing a chronic illness. This in turn necessitates more frequent medical attention and long-term care, leading to a greater demand for chronic disease management solutions. A report from the World Health Organization (WHO), a key player in global health, revealed in October 2024 that by 2030, one out of every six people globally will be aged 60 or above. The forecast for 2050 projects a global geriatric population of over 2.1 billion. As such, this growth in the older population significantly fuels the development of the chronic disease management market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6984&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Chronic Disease Management Market?
The emergence of advanced technology is a notable trend gaining traction in the chronic disease management market. Sophisticated technologies, such as artificial intelligence (AI), are being employed to manage chronic illnesses. Utilizing AI allows healthcare professionals to see improvements in early intervention and patient outcomes for individuals battling heart disease, cancer, and diabetes. For example, in February 2022, Biofourmis, an AI-driven virtual care and digital pharmaceutical company based in Boston, introduced Biofourmis Care. This service delivers exceptional remote care to patients with chronic conditions. The focus of Biofourmis Care is to increase adherence to care advice from providers and identify clinical deterioration patterns to facilitate early interventions.
What Are the Emerging Segments in the Chronic Disease Management Market?
The chronic disease managementmarket covered in this report is segmented -
1) By Service: Consulting Service, Implementation Service, Educational Service
2) By Delivery Mode: On-premise, Cloud-based, Web-based
3) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders
4) By End User: Providers, Payers
Subsegments:
1) By Consulting Service: Disease Management Assessment, Program Design And Development, Performance Evaluation
2) By Implementation Service: Technology Integration, Workflow Optimization, Care Coordination
3) By Educational Service: Patient Education Programs, Provider Training, Community Awareness Initiatives
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6984&type=smp
Who Are the Global Leaders in the Chronic Disease Management Market?
Major companies operating in the chronic disease management market include Allscripts Healthcare Solutions Inc. (now known as Veradigm Inc. ), ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, ExlServings Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Alkeus Pharmaceuticals, Healthy. io, Immunic Inc., GlaxoSmithKline (GSK), GEOVAX INC., Bluebird Bio, Optum Inc., Omada Health
Which are the Top Profitable Regional Markets for the Chronic Disease Management Industry?
North America was the largest region in the chronic disease management market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6984
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Disease Management Market Trends That Will Shape the Next Decade: Insights from AI-Powered Solutions Transforming Chronic Disease Management here
News-ID: 4222300 • Views: …
More Releases from The Business Research Company

The Buy-Now-Pay-Later Market Rides The Online Payment Wave: The Driving Engine B …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Buy Now Pay Later Market Size Growth Forecast: What to Expect by 2025?
Over the past several years, there has been a significant expansion in the size of the buy now pay later market. It is projected to increase from $231.51 billion in 2024 to $342.13 billion in 2025…

Steady Expansion Forecast for Block Chain In Healthcare Market, Projected to Rea …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Block Chain In Healthcare Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the last few years, the size of the healthcare blockchain market has soared. It is projected to rise from $2.23 billion in 2024 to $3.03 billion in 2025, boasting a Compound Annual…

E-Commerce Boom Fuels Growth In The Autonomous Last-Mile Delivery Market Emerges …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Autonomous Last Mile Delivery Market Through 2025?
The market for autonomous last mile delivery has witnessed significant expansion in the past few years. There is an expected surge from $29.66 billion in 2024 to $38.01 billion by 2025, with a compound annual…

Global Automation As A Service Market Growth Accelerates: Strategic Forecast Pre …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Automation As A Service Industry Market Size Be by 2025?
The market size of automation as a service has experienced a significant surge over the past few years. It is projected to increase from $7.24 billion in 2024 to $8.72 billion in 2025, reflecting a compound…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…